Table 3 Phenotypic and Genotypic antibiotic resistance rates in CRKP isolates

Ampicillin

51(100%)

Cotrimoxazole

51(100%)

Sulfonamide

sul1

51(100%)

sul2

29(56.8%)

Cefixime

51(100%)

ESBL+

bla _TEM

51(100%)

n:51

AmpC+

bla _CIT

28(54.9%)

Cefotaxime

51(100%)

bla _CTX−M1

51(100%)

bla _CMY−2

26(51%)

bla _SHV

51(100%)

bla _ACC

4(7.8%)

Ceftriaxone

51(100%)

bla _CTX−M15

49(96%)

bla _FOX

0%

Ceftazidime

51(100%)

bla _CTX−M2

0%

bla _MOX

0%

bla _CTX−M8

0%

bla _DHA

0%

Gentamicin

47(92.1%)

Amikacin

26(50.9%)

Tetracycline

27(52.9%)

Tetracycline

tetA

19(70.4%)

Doxycycline

27(52.9%)

Minocycline

22(43.1%)

tetB

11(40.7%)

Tigecycline

2(3.9%)

Ciprofloxacin

49(96%)

Fluoroquinolone

gyrA

28(57.1%)

qnrB

26(53%)

Levofloxacin

49(96%)

qnrS

21(42.8%)

qnrA

13(26.5%)

parC

0%

Ampicillin/sulbactam

51(100%)

Piperacillin/tazobactam

51(100%)

Imipenem

50(98%)

Carbapenemase

Ambler class A blactamases

bla _GES

11(21.5%)

bla _KPC

0%

Ambler class B metallo- β -lactamases (MBLs)

bla _NDM

36(70.5%)

bla _VIM

9(17.6%)

Meropenem

51(100%)

bla _SIM

0%

bla _GIM

0%

Doripenem

51(100%)

bla _IMP

0%

Ambler class D b-lactamases

bla _Oxa−48

46(90.1%)

Ertapenem

51(100%)

Aztreonam

50(98%)

Colistin

4(7.8%)

Fosfomycin

5(9.8%)

Integrase

int1

51(100%)

int2

39(76.5%)

int3

0%

Quaternary Ammonium Compounds

qac

48(94.1%)

MDR

51(100%)

XDR

14(27.4%)